10-Q/A Filing

HEALTHTECH SOLUTIONS, INC./UT CIK: 1307624 Q2 2021

Filing Information

Form Type	10-Q/A
Accession Number	`0001262463-21-000414`
Period End Date	20210630
Filing Date	20210825
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	hltt_10qa_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 70 Cash Flow Statement 59 Stockholders Equity 27

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Series A Preferred Stock,shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Series A Preferred Stock,shares authorized	`PreferredStockSharesAuthorized`	2.00M	shares	Point-in-time
Series A Preferred Stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$129.00K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$907.32K	USD	Point-in-time
Series A Preferred Stock, par value per share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series A Preferred Stock, shares issued	`PreferredStockSharesIssued`	156,837.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.00K	USD	Point-in-time
Series A Preferred Stock, shares issued	`PreferredStockSharesIssued`	127,430.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$157.58K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.06M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$139.00K	USD	Point-in-time
Series A Preferred Stock,shares outstanding	`PreferredStockSharesOutstanding`	127,430.00	shares	Point-in-time
Series A Preferred Stock,shares outstanding	`PreferredStockSharesOutstanding`	156,837.00	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$25.93K	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$6.48K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Goodwill	`Goodwill`	$1.10M	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Assets	`Assets`	$164.92K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.70M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	29.15M	shares	Point-in-time
Total Assets	`Assets`	$2.18M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	29.15M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.70M	shares	Point-in-time
Convertible debentures payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$323.91K	USD	Point-in-time
Convertible debentures payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$325.82K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesAndOtherLiabilities`	$469.29K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesAndOtherLiabilities`	-	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$3.79K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$80.17K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$159.88K	USD	Point-in-time
Loan From related party	`DueToRelatedPartiesCurrent`	$353.91K	USD	Point-in-time
Loan From related party	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$83.96K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$983.08K	USD	Point-in-time
Convertible debentures payable, net of discount	`ConvertibleDebtNoncurrent`	$305.68K	USD	Point-in-time
Convertible debentures payable, net of discount	`ConvertibleDebtNoncurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	$337.87K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	$643.56K	USD	Point-in-time
Total Long Term Liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$727.52K	USD	Point-in-time
Total Liabilities	`Liabilities`	$983.08K	USD	Point-in-time
Series A preferred stock, $.001 par value, 2,000,000 authorized, 127,430 and 156,837 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$127.00	USD	Point-in-time
Series A preferred stock, $.001 par value, 2,000,000 authorized, 127,430 and 156,837 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$157.00	USD	Point-in-time
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,145,933 and 9,701,269 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$9.70K	USD	Point-in-time
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,145,933 and 9,701,269 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$29.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.66M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$866.25K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.44M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-6.51M	USD	Point-in-time
Stockholders' Equity (Deficit) Attributable to the Company	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.18M	USD	Point-in-time
Stockholders' Equity (Deficit) Attributable to the Company	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Non Controlling Interest	`MinorityInterest`	$8.46K	USD	Point-in-time
Non Controlling Interest	`MinorityInterest`	-	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-87.11K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$43.51K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$1.19M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-851.91K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$134.17K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$164.92K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$2.18M	USD	Point-in-time

Income Statement 70 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$857.20K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$19.16K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$932.35K	USD	2 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$32.30K	USD	2 Qtrs
General and administrative-related party	`GeneralAndAdministrativeExpense`	$41.34K	USD	1 Quarter
General and administrative-related party	`GeneralAndAdministrativeExpense`	$333.55K	USD	2 Qtrs
General and administrative-related party	`GeneralAndAdministrativeExpense`	$258.88K	USD	1 Quarter
General and administrative-related party	`GeneralAndAdministrativeExpense`	$69.73K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$196.73K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$25.73K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$19.93K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$111.79K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentInProcess`	$19.00K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentInProcess`	$37.50K	USD	2 Qtrs
Research and development related party	`ResearchAndDevelopmentInProcess`	$268.00K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentInProcess`	$286.00K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$19.44K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$9.72K	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$19.44K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$9.72K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.77M	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$109.15K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$184.71K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.51M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-184.71K	USD	2 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-1.51M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	-	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-1.77M	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$328.54K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$367.14K	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	-	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$-2.94M	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$-2.93M	USD	2 Qtrs
Total Other Expenses	`OtherNonoperatingIncomeExpense`	$-3.30M	USD	2 Qtrs
Total Other Expenses	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Total Other Expenses	`OtherNonoperatingIncomeExpense`	$-3.27M	USD	1 Quarter
Total Other Expenses	`OtherNonoperatingIncomeExpense`	-	USD	2 Qtrs
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-184.71K	USD	2 Qtrs
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	-	USD	1 Quarter
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-4.78M	USD	1 Quarter
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-5.07M	USD	2 Qtrs
Provision for income tax	`OtherComprehensiveIncomeLossBeforeTax`	-	USD	2 Qtrs
Provision for income tax	`OtherComprehensiveIncomeLossBeforeTax`	-	USD	1 Quarter
Provision for income tax	`OtherComprehensiveIncomeLossBeforeTax`	-	USD	1 Quarter
Provision for income tax	`OtherComprehensiveIncomeLossBeforeTax`	-	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-109.15K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-75.56K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-293.88K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-184.71K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-5.07M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-4.78M	USD	1 Quarter
Net loss attributable to non-controlling interest	`IncomeLossAttributableToNoncontrollingInterest`	$1.21K	USD	2 Qtrs
Net loss attributable to non-controlling interest	`IncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net loss attributable to non-controlling interest	`IncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss attributable to non-controlling interest	`IncomeLossAttributableToNoncontrollingInterest`	$1.21K	USD	1 Quarter
Net Loss attributable to Controlling Interest	`NetLossAttributableToControllingInterest`	$-184.71K	USD	2 Qtrs
Net Loss attributable to Controlling Interest	`NetLossAttributableToControllingInterest`	$-5.07M	USD	2 Qtrs
Net Loss attributable to Controlling Interest	`NetLossAttributableToControllingInterest`	$-109.15K	USD	1 Quarter
Net Loss attributable to Controlling Interest	`NetLossAttributableToControllingInterest`	$-4.77M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	2 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Basic and diluted weighted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.25M	shares	2 Qtrs
Basic and diluted weighted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	20.74M	shares	1 Quarter

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-109.15K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-75.56K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-293.88K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-184.71K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.07M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.78M	USD	1 Quarter
Amortization expense	`AdjustmentForAmortization`	$19.44K	USD	2 Qtrs
Amortization expense	`AdjustmentForAmortization`	$9.72K	USD	1 Quarter
Amortization expense	`AdjustmentForAmortization`	$19.44K	USD	2 Qtrs
Amortization expense	`AdjustmentForAmortization`	$9.72K	USD	1 Quarter
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Amortization of discount on convertible debentures	`AmortizationOfDebtDiscountPremium`	$351.21K	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	-	USD	2 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.03M	USD	2 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	-	USD	2 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	$15.87K	USD	2 Qtrs
Change in fFair value ofchange in derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$2.93M	USD	2 Qtrs
Change in fFair value ofchange in derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-147.58K	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$98.69K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-34.34K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	-	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$69.34K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-199.61K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-699.22K	USD	2 Qtrs
Cash paid for purchase of Varian, net of cash acquired	`CashAcquiredFromAcquisition`	-	USD	2 Qtrs
Cash paid for purchase of Varian, net of cash acquired	`CashAcquiredFromAcquisition`	$437.06K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-437.06K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from loan from related party	`ProceedsFromLoanFromRelatedParty`	-	USD	2 Qtrs
Proceeds from loan from related party	`ProceedsFromLoanFromRelatedParty`	$118.08K	USD	2 Qtrs
Proceeds from convertible debenture	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from convertible debenture	`ProceedsFromConvertibleDebt`	$50.00K	USD	2 Qtrs
Settlement of loan from related party	`SettlementOfLoanFromRelatedParty`	$-50.54K	USD	2 Qtrs
Settlement of loan from related party	`SettlementOfLoanFromRelatedParty`	-	USD	2 Qtrs
Capital contributions	`ProceedsFromContributionsFromParent`	$4.56K	USD	2 Qtrs
Capital contributions	`ProceedsFromContributionsFromParent`	-	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.79M	USD	2 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.79M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$94.05K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.91M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$94.05K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$778.33K	USD	2 Qtrs
Net increase (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-105.56K	USD	2 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$191.00	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$907.32K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$105.75K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$191.00	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$907.32K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$105.75K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$61.00	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	2 Qtrs
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Acquired noncontrolling interest in business acquisition	`AcquiredNoncontrollingInterestInBusinessAcquisition`	-	USD	2 Qtrs
Acquired noncontrolling interest in business acquisition	`AcquiredNoncontrollingInterestInBusinessAcquisition`	$523.27K	USD	2 Qtrs

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance, amount	`StockholdersEquity`	$-87.11K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$43.51K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$1.19M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-851.91K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$134.17K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-562.60K	USD	Point-in-time
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$4.56K	USD	1 Quarter
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$65.55K	USD	1 Quarter
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$28.50K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-109.15K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-75.56K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-293.88K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-184.71K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.07M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-4.78M	USD	1 Quarter
Issuance of common stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	8.96M	shares	1 Quarter
Issuance of common stock, shares	`StockIssuedDuringPeriodSharesNewIssues`	3.51M	shares	Point-in-time
Issuance of common stock, amount	`StockIssuedDuringPeriodValueNewIssues`	$2.82M	USD	1 Quarter
Issuance of Series C Preferred for acquisition of Varian, amount	`IssuanceOfSeriesCPreferredForAcquisitionOfVarianAmount`	$-9.67K	USD	1 Quarter
Non-controlling interest associated with acquisition of Varian	`NonControllingInterestAssociatedWithAcquisitionOfVarian`	$9.68K	USD	1 Quarter
Conversion of Debentures into common stock, amount	`ConversionOfStockAmountIssued1`	$4.00M	USD	1 Quarter
Balance, amount	`StockholdersEquity`	$-87.11K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$43.51K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$1.19M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-851.91K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$134.17K	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-562.60K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.